← Back to Search

Mindfulness Meditation for Pulmonary Hypertension (MMPH) for Pulmonary Hypertension (MMPH Trial)

N/A

Waitlist Available

Led By Tania Von Visger

Research Sponsored by State University of New York at Buffalo

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and at the end of the study intervention (week #8)

Awards & highlights

No Placebo-Only Group

Summary

This trial tests a mindfulness meditation program delivered via Zoom and a mobile app for adults in Western New York. The program aims to reduce stress and improve well-being through meditation, gentle movements, and restorative poses.

Eligible Conditions

Pulmonary Hypertension

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and at the end of the study intervention (week #8)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and at the end of the study intervention (week #8)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and at the end of the study intervention (week #8) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change From Baseline in Depressive Symptoms on the 27-point Patient Health Questionnaire-9 Scales (PHQ-9) to Week #8.

Secondary study objectives

Change From Baseline in Mindfulness Level on the 40-point Cognitive and Affective Mindfulness Scale-Revised (CAMS-R) to Week #8.

Change From Baseline in PH-related Quality of Life on the 50-point EmPHasis-10 Scales to Week #8.

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Treatment ArmExperimental Treatment1 Intervention

This treatment Arm will receive MMPH intervention first, while the wait-listed group waits until this group is complete. Then the wait-listed group will receive the same intervention after the first group completes it.

Group II: Comparison Arm or Waited List ArmActive Control1 Intervention

This active comparator Arm will not receive MMPH intervention at the beginning. They will receive the intervention once the Treatment Group completed the intervention.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Mindfulness Meditation for Pulmonary Hypertension (MMPH)

2022

N/A

~20

Do I qualify?Apply below to find out